Certain A Shares of Frontier Biotechnologies Inc. are subject to a Lock-Up Agreement Ending on 28-OCT-2023. These A Shares will be under lockup for 1101 days starting from 22-OCT-2020 to 28-OCT-2023.

Details:
The company's controlling shareholder, Dong Xie, Baobab Pharmaceuticals Limited, Nanjing Jianmu Biotechnology Co., Ltd., Nanjing Jianmu Business Consulting Partnership (Limited Partnership) and Nanjing Yuhang Chunhua Enterprise Management Center (limited partnership) and Nanjing Jianshu Enterprise Management Center (Limited Partnership) committed that within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months. After the expiry of the lock-up period (including the extended lock-up period), the parties promise that yearly transfer of shares made by them will not exceed 25% of the holding, both direct and indirect, held by the present parties.

Wang Changjin, Lu Rongjian, Oh Isamu and Lü Hangzhou, all other shareholders of the Company, Chongqing Frontier Biotechnology Co., Ltd, Nanjing Jianshu Enterprise Management Center (Limited Partnership), Nanjing Medical Bridge Enterprise Management Center (Limited Partnership), Nanjing Yugong Enterprise Management Partnership (Limited Partnership), Beijing Dingze Swift Technology Co., Ltd, Shenzhen Qianhai Yifeng Taihe Equity Investment Fund Enterprise (Limited Partnership), Chongqing Yusheng Hongkun Enterprise Management Consulting Co., Ltd, Nanjing Jiangning (University) Science and Education Innovation Park Co., Ltd, Nanjing Binhu Business Information Consulting Co., Ltd, Nanjing Xiangshui Ditai Business Information Consulting Co., Ltd committed that within 12 months since the date of listing of the present shares, there will be no transfers nor entrustment of shares to any third party nor repurchase by the Company. After the expiry of the lock-up period (including the extended lock-up period), the parties promise that yearly transfer of shares made by them will not exceed 25% of the holding, both direct and indirect, held by the present parties.